Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 33, 2019 - Issue 20
300
Views
1
CrossRef citations to date
0
Altmetric
Short Communications

A new phenolic glycoside from the Idesia polycarpa Maxim. leaves

, , , , , , , & show all
Pages 3016-3020 | Received 21 Apr 2018, Accepted 10 Aug 2018, Published online: 09 Dec 2018
 

Abstract

Phytochemical investigation on the ethyl acetate extract of Idesia polycarpa Maxim. Leaves led to the isolation of four phenolic glycoside isomers (1–4). Compound 2 appeared to be new reported phenolic glycoside, while compound 1 was the first time isolated from the titled species. Their structures were established by IR, UV, HRESI-MS and 1D and 2D NMR spectroscopies analysis and comparison of spectral data with previously reported data. The compounds 3 and 4 showed stronger activity of scavenging the DPPH free radical than the other two compounds, while the compounds 1 and 2 showed a significant activity of scavenging the ABTS free radical. Compounds 2 and 4 exhibited stronger cytotoxicity against HepG2 cell lines compared to compounds 1 and 3. Moreover, compound 3 presented the highest cytotoxicity against MCF cell lines with IC50 value of 37.17 ± 0.26 μg/mL than compounds 1, 2 and 4.

Disclosure statement

The authors declare no competing financial interest.

Additional information

Funding

This work was supported by the project Sichuan Science and Technology Poverty Alleviation [grant number 2016NZYZF] and the project Luzhou Science and Technology [grant number 2016CDLZ-Z20].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.